Sign in
4

Changes in Ownership

ENANTA PHARMACEUTICALS INC Filed Acc 0001062993-21-012213

Sr. VP & Chief Medical Officer sold 13,523 shares at an average $86.35 ($1,167,690)

  • Sr. VP & Chief Medical Officer acquired 13,523 shares (option exercise)
  • Sr. VP & Chief Medical Officer gave up 842 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Adda Nathalie · Sr. VP & Chief Medical Officer

Table I: Non-derivative

10 lines
Date Transaction Shares Price Value Owned after D/I
2021-12-01 Shares withheld for taxes : show line 1 in the form −842 $87.68 $73,827 32,902 D
2021-12-01 Exercise or conversion : show line 2 in the form +8,750 $43.46 $380,275 41,652 D
2021-12-01 Exercise or conversion : show line 3 in the form +4,773 $48.52 $231,586 46,425 D
2021-12-01 Sale : show line 4 in the form −1,587 $84.81 $134,593 44,838 D
2021-12-01 Sale : show line 5 in the form −5,736 $85.49 $490,371 39,102 D
2021-12-01 Sale : show line 6 in the form −2,700 $86.45 $233,415 36,402 D
2021-12-01 Sale : show line 7 in the form −1,500 $87.60 $131,400 34,902 D
2021-12-01 Sale : show line 8 in the form −900 $88.31 $79,479 34,002 D
2021-12-01 Sale : show line 9 in the form −899 $89.33 $80,308 33,103 D
2021-12-01 Sale : show line 10 in the form −201 $90.17 $18,124 32,902 D
Open-market sales · 13,523 sh · avg $86.35 · $1,167,690

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-12-01 Exercise or conversion : show line 11 in the form Stock Option (Right to Buy) −8,750 46,020 D
2021-12-01 Exercise or conversion : show line 12 in the form Stock Option (Right to Buy) −4,773 9,180 D
Loading xslF345X03/form4.xml…